Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 20, Issue 35, Pages 12581
Publisher
Baishideng Publishing Group Inc.
Online
2014-09-23
DOI
10.3748/wjg.v20.i35.12581
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sorafenib for non-selected patient population with advanced hepatocellular carcinoma: efficacy and safety data according to liver function
- (2012) Jon Zugazagoitia et al. Clinical & Translational Oncology
- Management of HCC
- (2012) Carlos Rodríguez de Lope et al. JOURNAL OF HEPATOLOGY
- Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma
- (2012) Cui-Xia Qiao WORLD JOURNAL OF GASTROENTEROLOGY
- Assessment of quality of life for the patients with cervical cancer at different clinical stages
- (2012) Yao Xie et al. Chinese Journal of Cancer
- Complete response for advanced liver cancer during sorafenib therapy: Case Report
- (2011) Rodolfo Sacco et al. BMC GASTROENTEROLOGY
- Comparison of tumor response by Response Evaluation Criteria in Solid Tumors (RECIST) and modified RECIST in patients treated with sorafenib for hepatocellular carcinoma
- (2011) Julien Edeline et al. CANCER
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- HFS-14, a Specific Quality of Life Scale Developed for Patients Suffering from Hand-Foot Syndrome
- (2011) V. Sibaud et al. ONCOLOGIST
- Complete Response of Advanced Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Sorafenib: A Case Report
- (2011) Tadashi Inuzuka et al. ONCOLOGY
- Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib
- (2010) B. Vincenzi et al. ONCOLOGIST
- Complete remission of unresectable hepatocellular carcinoma treated with reduced dose of sorafenib: a case report
- (2010) Sean Xiang Wang et al. Targeted Oncology
- Risk of Hand-Foot Skin Reaction with the Multitargeted Kinase Inhibitor Sunitinib in Patients with Renal Cell and Non–Renal Cell Carcinoma: A Meta-analysis
- (2009) David Chu et al. Clinical Genitourinary Cancer
- Risk of hand-foot skin reaction with sorafenib: A systematic review and meta-analysis
- (2008) David Chu et al. ACTA ONCOLOGICA
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolving Strategies for the Management of Hand-Foot Skin Reaction Associated with the Multitargeted Kinase Inhibitors Sorafenib and Sunitinib
- (2008) M. E. Lacouture et al. ONCOLOGIST
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started